 Sarepta Therapeutics NASDAQ:SRPT and NextCure NASDAQ:NXTC are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, profitability, risk, institutional ownership, earnings, dividends and analyst recommendations. Insider and Institutional Ownership 93.8 of Sarepta Therapeutics shares are owned by institutional investors. Comparatively, 73.1 of ... 